Zacks Small Cap Research on MSN

DYAI: Purchase Orders Rolling In

DYAI READ THE FULL DYAI RESEARCH REPORT Dyadic Applied BioSolutions, Inc. (NASDAQ:DYAI) announced third quarter 2025 results on November 12th, 2025, and held a conference call to discuss them after ...
ZME Science on MSN

Inside the Human Gene Editing Boom Driven by CRISPR Reshaping Everything From Medicine to Food

CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.